000289303 001__ 289303
000289303 005__ 20241111104046.0
000289303 0247_ $$2doi$$a10.1371/journal.pone.0300668
000289303 0247_ $$2pmid$$apmid:38578780
000289303 0247_ $$2pmc$$apmc:PMC10997103
000289303 0247_ $$2altmetric$$aaltmetric:161674572
000289303 037__ $$aDKFZ-2024-00698
000289303 041__ $$aEnglish
000289303 082__ $$a610
000289303 1001_ $$00000-0001-6526-4339$$aWaern, Ida$$b0
000289303 245__ $$aDisruption of the mast cell carboxypeptidase A3 gene does not attenuate airway inflammation and hyperresponsiveness in two mouse models of asthma.
000289303 260__ $$aSan Francisco, California, US$$bPLOS$$c2024
000289303 3367_ $$2DRIVER$$aarticle
000289303 3367_ $$2DataCite$$aOutput Types/Journal article
000289303 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1712566176_9969
000289303 3367_ $$2BibTeX$$aARTICLE
000289303 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000289303 3367_ $$00$$2EndNote$$aJournal Article
000289303 520__ $$aMast cells are effector cells known to contribute to allergic airway disease. When activated, mast cells release a broad spectrum of inflammatory mediators, including the mast cell-specific protease carboxypeptidase A3 (CPA3). The expression of CPA3 in the airway epithelium and lumen of asthma patients has been associated with a Th2-driven airway inflammation. However, the role of CPA3 in asthma is unclear and therefore, the aim of this study was to investigate the impact of CPA3 for the development and severity of allergic airway inflammation using knockout mice with a deletion in the Cpa3 gene. We used the ovalbumin (OVA)- and house-dust mite (HDM) induced murine asthma models, and monitored development of allergic airway inflammation. In the OVA model, mice were sensitized with OVA intraperitoneally at seven time points and challenged intranasally (i.n.) with OVA three times. HDM-treated mice were challenged i.n. twice weekly for three weeks. Both asthma protocols resulted in elevated airway hyperresponsiveness, increased number of eosinophils in bronchoalveolar lavage fluid, increased peribronchial mast cell degranulation, goblet cell hyperplasia, thickening of airway smooth muscle layer, increased expression of IL-33 and increased production of allergen-specific IgE in allergen-exposed mice as compared to mocktreated mice. However, increased number of peribronchial mast cells was only seen in the HDM asthma model. The asthma-like responses in Cpa3-/- mice were similar as in wild type mice, regardless of the asthma protocol used. Our results demonstrated that the absence of a functional Cpa3 gene had no effect on several symptoms of asthma in two different mouse models. This suggest that CPA3 is dispensable for development of allergic airway inflammation in acute models of asthma in mice.
000289303 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000289303 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000289303 7001_ $$aAkula, Srinivas$$b1
000289303 7001_ $$aAllam, Venkata Sita Rama Raju$$b2
000289303 7001_ $$aTaha, Sowsan$$b3
000289303 7001_ $$0P:(DE-He78)ec832b560b08e92bd09a1ad2bbe702dc$$aFeyerabend, Thorsten B$$b4$$udkfz
000289303 7001_ $$aÅbrink, Magnus$$b5
000289303 7001_ $$00000-0003-3067-7875$$aWernersson, Sara$$b6
000289303 773__ $$0PERI:(DE-600)2267670-3$$a10.1371/journal.pone.0300668$$gVol. 19, no. 4, p. e0300668 -$$n4$$pe0300668 -$$tPLOS ONE$$v19$$x1932-6203$$y2024
000289303 8564_ $$uhttps://inrepo02.dkfz.de/record/289303/files/journal.pone.0300668.pdf
000289303 8564_ $$uhttps://inrepo02.dkfz.de/record/289303/files/journal.pone.0300668.pdf?subformat=pdfa$$xpdfa
000289303 909CO $$ooai:inrepo02.dkfz.de:289303$$pVDB
000289303 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ec832b560b08e92bd09a1ad2bbe702dc$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000289303 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000289303 9141_ $$y2024
000289303 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2022-04-12T10:14:32Z
000289303 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2022-04-12T10:14:32Z
000289303 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2022-04-12T10:14:32Z
000289303 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2022-04-12T10:14:32Z
000289303 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-25
000289303 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-25
000289303 9201_ $$0I:(DE-He78)D110-20160331$$kD110$$lZelluläre Immunologie$$x0
000289303 980__ $$ajournal
000289303 980__ $$aVDB
000289303 980__ $$aI:(DE-He78)D110-20160331
000289303 980__ $$aUNRESTRICTED